Literature DB >> 17070802

Cell-specific differential modulation of human trabecular meshwork cells by selective adenosine receptor agonists.

Mike O Karl1, Kim Peterson-Yantorno, Mortimer M Civan.   

Abstract

Activation of A1 and A2A subtype adenosine receptors (AR) likely exert opposing effects on outflow of aqueous humor, and thereby, on intraocular pressure. Selective agonists of adenosine receptor (AR) subtypes have previously been applied to trabecular meshwork (TM) and Schlemm's canal (SC) cells to identify the site(s) of differential purinergic modulation. However, the apparent changes in volume monitored by previously measuring projected cell area might have partially reflected cell contraction and relaxation. In addition, whole-cell current responses of the TM cells previously described were highly variable following application of selective A1, A2A and A3 agonists. The complexity of the electrophysiologic responses may have reflected cell heterogeneity of the populations harvested from collagenase digestion of TM explants. We now report measurements of TM-cell volume using calcein fluorescence quenching, an approach independent of contractile state. Furthermore, we have applied selective AR agonists to a uniform population of human TM cells, the hTM5 cell line. A1, but not A2A or A3, AR agonists triggered TM-cell shrinkage. Both A1 and A2A AR agonists produced reproducible increases in TM-cell whole-cell currents of similar magnitude. The results suggest that previous measurements of explant-derived TM cells may have reflected a range of responses from phenotypically different cell populations, and that the opposing effects of A1 and A2A agonists on outflow resistance are not likely to be mediated by actions on a single population of TM cells. These opposing effects might reflect AR responses by two or more subpopulations of TM cells, by TM and SC cells or by inner-wall SC cells, alone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070802      PMCID: PMC1764820          DOI: 10.1016/j.exer.2006.09.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  44 in total

1.  The role of NaKCl cotransport in blood-to-aqueous chloride fluxes across rabbit ciliary epithelium.

Authors:  R B Crook; K Takahashi; A Mead; J J Dunn; M L Sears
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Experimental studies on the trabecular meshwork in primates.

Authors:  J W ROHEN
Journal:  Arch Ophthalmol       Date:  1963-03

Review 3.  'What controls aqueous humour outflow resistance?'.

Authors:  Mark Johnson
Journal:  Exp Eye Res       Date:  2006-01-04       Impact factor: 3.467

4.  Caldesmon effects on the actin cytoskeleton and cell adhesion in cultured HTM cells.

Authors:  Inna Grosheva; Jason L Vittitow; Polina Goichberg; B'Ann True Gabelt; Paul L Kaufman; Terete Borrás; Benjamin Geiger; Alexander D Bershadsky
Journal:  Exp Eye Res       Date:  2006-06       Impact factor: 3.467

5.  Swelling-activated Cl- channels support Cl- secretion by bovine ciliary epithelium.

Authors:  Chi Wai Do; Kim Peterson-Yantorno; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

Review 6.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

7.  Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells.

Authors:  Mike O Karl; Johannes C Fleischhauer; W Daniel Stamer; Kim Peterson-Yantorno; Claire H Mitchell; R A Stone; M M Civan
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-08       Impact factor: 4.249

8.  Effects of Na-K-2Cl cotransport regulators on outflow facility in calf and human eyes in vitro.

Authors:  L A Al-Aswad; H Gong; D Lee; M E O'Donnell; J D Brandt; W J Ryan; A Schroeder; K A Erickson
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-07       Impact factor: 4.799

9.  Similarity of A(3)-adenosine and swelling-activated Cl(-) channels in nonpigmented ciliary epithelial cells.

Authors:  D A Carré; C H Mitchell; K Peterson-Yantorno; M Coca-Prados; M M Civan
Journal:  Am J Physiol Cell Physiol       Date:  2000-08       Impact factor: 4.249

10.  Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma.

Authors:  Ursula Schlötzer-Schrehardt; Matthias Zenkel; Ulrich Decking; Daniela Haubs; Friedrich E Kruse; Anselm Jünemann; Miguel Coca-Prados; Gottfried O H Naumann
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-06       Impact factor: 4.799

View more
  6 in total

Review 1.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

2.  Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.

Authors:  Zhao Wang; Chi Wai Do; Marcel Y Avila; Kim Peterson-Yantorno; Richard A Stone; Zhan-Guo Gao; Bhalchandra Joshi; Pedro Besada; Lak Shin Jeong; Kenneth A Jacobson; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2009-10-28       Impact factor: 3.467

3.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

4.  Novel ocular antihypertensive compounds in clinical trials.

Authors:  June Chen; Stephen A Runyan; Michael R Robinson
Journal:  Clin Ophthalmol       Date:  2011-05-20

Review 5.  Medical Management of Glaucoma in the 21st Century from a Canadian Perspective.

Authors:  Paul Harasymowycz; Catherine Birt; Patrick Gooi; Lisa Heckler; Cindy Hutnik; Delan Jinapriya; Lesya Shuba; David Yan; Radmila Day
Journal:  J Ophthalmol       Date:  2016-11-08       Impact factor: 1.909

6.  Regulatory Roles of Anoctamin-6 in Human Trabecular Meshwork Cells.

Authors:  Juni Banerjee; Chi-Ting Leung; Ang Li; Kim Peterson-Yantorno; Huan Ouyang; W Daniel Stamer; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.